spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Searching News Database:  movement disorder 

 HSMN NewsFeed - 2 Apr 2026
StairMed Secures RMB 500 Million Financing Led by Alibaba, Joined by Tencent
Devices Neurosurgery Venture Capital
 HSMN NewsFeed - 3 Mar 2026
Insightec Announces National Reimbursement in France for MR-Guided Focused Ultrasound to Treat Essential Tremor
Devices Neurology Reimbursement
 HSMN NewsFeed - 12 Nov 2025
Modulight Biotherapeutics Announces $12 Million Seed Funding for Novel Optogenetic Therapy to Treat Neurological Disorders
Devices Neurology Venture Capital
 HSMN NewsFeed - 5 Feb 2025
Newronika Receives Investigational Device Exemption (IDE) from FDA to Initiate U.S. Clinical Trial of Adaptive DBS System
Devices Neurology FDA
 HSMN NewsFeed - 13 Jan 2025
Medtronic Achieves CE Mark Approval for BrainSense Adaptive Deep Brain Stimulation and Electrode Identifier, a Groundbreaking Advance In Personalized, Sensing-Enabled Care for People with Parkinson's Through Innovative Brain-Computer Interface Technology
Devices Neurosurgery Regulatory
 HSMN NewsFeed - 4 Mar 2024
Insightec's Groundbreaking Transcranial MR-Guided Focused Ultrasound (MRgFUS) Approved for Additional Reimbursement for Essential Tremor in Germany
Devices Neurology Reimbursement
 HSMN NewsFeed - 17 Aug 2023
AbbVie Announces European Commission Approval of AQUIPTA(R) (atogepant) for the Preventive Treatment of Migraine in Adults
Biopharmaceuticals Neurology Regulatory
 HSMN NewsFeed - 21 Apr 2023
AbbVie Announces Late-Breaking Results from Phase 3 Trial Evaluating Atogepant (QULIPTA(R)) for the Preventive Treatment of Episodic Migraine Among Patients with Prior Treatment Failure at the 2023 AAN Annual Meeting
Biopharmaceuticals Neurology
 HSMN NewsFeed - 22 Dec 2022
INSIGHTEC Announces Positive Coverage Decision by Anthem for MR-Guided Focused Ultrasound to Treat Essential Tremor
Devices Neurology Reimbursement
 HSMN NewsFeed - 3 Nov 2022
Emalex Biosciences Announces $250 Million Financing Round to Advance Investigational New Drug for Tourette Syndrome
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 5 Jul 2022
Lyra Therapeutics Announces Appointment of Richard Nieman, MD, as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Apr 2022
AbbVie terminates collaboration with BioArctic on alpha-synuclein portfolio
Biopharmaceuticals
 HSMN NewsFeed - 7 Feb 2022
Vensica Closes $19 Million Round with Investment from Strategic Partner Merz
Devices Drug Delivery Urology Venture Capital
 HSMN NewsFeed - 11 Jan 2022
Nine Square Therapeutics Appoints Robert Paul as CEO
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 3 Nov 2021
Insightec Announces FDA Approval of Exablate Neuro for the Treatment of Parkinson's Disease
Devices Neurology FDA
 HSMN NewsFeed - 7 Jun 2021
FDA Approves First-of-its-Kind SenSight(TM) Directional Lead System for DBS Therapy
Devices Neurology FDA
 HSMN NewsFeed - 5 May 2021
Jazz Pharmaceuticals Completes Acquisition of GW Pharmaceuticals
Biopharmaceuticals Neurology Mergers & Acquisitions
 HSMN NewsFeed - 6 Apr 2021
Seelos Therapeutics Announces a Strategic Device Partnership with AptarGroup, Inc.
Biopharmaceuticals Devices Drug Delivery
 HSMN NewsFeed - 23 Mar 2021
Emalex Biosciences Raises $35 Million in Series C Preferred Stock to Advance Tourette Syndrome and Stuttering Clinical Trials
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 22 Mar 2021
Medtronic Receives CE Mark Approval for SenSight(TM) Directional Lead System for DBS Therapy
Devices Neurology Regulatory
 HSMN NewsFeed - 8 Mar 2021
Abbott Introduces NeuroSphere(TM) Virtual Clinic, First-of-its-Kind Remote Neuromodulation Patient-Care Technology in the U.S.
Devices Neurology Product Launch
 HSMN NewsFeed - 22 Jan 2021
Boston Scientific Receives FDA Approval For The Vercise Genus(TM) Deep Brain Stimulation System
Devices Neurology FDA
 HSMN NewsFeed - 30 Nov 2020
PTC Therapeutics Announces Initiation of Global Phase 3 Clinical Trial to Evaluate Vatiquinone in Friedreich Ataxia
Biopharmaceuticals
 HSMN NewsFeed - 28 Oct 2020
Accuray Announces Agreement with Brainlab to Expand CyberKnife(R) Platform Treatment Capabilities for the Neuro-Radiosurgery Market
Devices Neurosurgery Oncology
 HSMN NewsFeed - 26 Oct 2020
Jazz Pharmaceuticals Acquires SpringWorks Therapeutics' FAAH Inhibitor Program
Biopharmaceuticals Licensing Acquisitions
 HSMN NewsFeed - 29 Jul 2020
Biotech Vico Therapeutics raises $31 million (€27 million) in Series A financing round to advance therapies for rare central nervous system diseases
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 23 Jul 2020
Abbott Receives FDA Approval for iOS-Compatible App Allowing People Living With Chronic Pain and Movement Disorders to Personalize Therapy Via Their Mobile Device
Devices Neurology FDA
 HSMN NewsFeed - 22 Jul 2020
Jazz Pharmaceuticals Announces U.S. FDA Approval of Xywav(TM) (calcium, magnesium, potassium, and sodium oxybates) Oral Solution for Cataplexy or Excessive Daytime Sleepiness Associated with Narcolepsy
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 11 May 2020
Jazz Pharmaceuticals Announces Appointment Of Kim Sablich As Executive Vice President, General Manager Of North America
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Apr 2020
Neurocrine Biosciences Announces FDA Approval of Once-Daily ONGENTYS(R) (opicapone) as an Add-On Treatment for Patients with Parkinson's Disease Experiencing "Off" Episodes
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 24 Jan 2020
Abbott Receives Expanded Indication From the U.S. FDA for Directional Deep Brain Stimulation System to Treat Parkinson's Disease
Devices Neurology FDA
 HSMN NewsFeed - 30 Oct 2019
Biogen and Alkermes Announce FDA Approval of VUMERITY(TM) (diroximel fumarate) for Multiple Sclerosis
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 31 Jul 2019
REGENXBIO Announces New License Agreement with Pfizer for the Treatment of Friedreich's Ataxia Using NAV(R) AAV9 Vector
Biopharmaceuticals Neurology Licensing
 HSMN NewsFeed - 16 Apr 2019
Cerebral Therapeutics Strengthens Clinical Development Leadership with Strategic Appointments
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 25 Jan 2019
Functional Neuromodulation Announces CEO Leadership Transition
Devices Neurology Personnel
 HSMN NewsFeed - 4 Jan 2019
Allevion Therapeutics Hires New CEO and Initiates Series A Funding
Devices Personnel
 HSMN NewsFeed - 2 Aug 2018
Abbott Expands its Directional Deep Brain Stimulation Therapy by Offering New MR-Conditional Labeling
Devices Neurology FDA
 HSMN NewsFeed - 24 Jul 2018
AbbVie Receives U.S. FDA Approval of ORILISSA(TM) (elagolix) for the Management of Moderate to Severe Pain Associated with Endometriosis
Biopharmaceuticals FDA Product Launch
 HSMN NewsFeed - 5 Jun 2018
Cytrellis Biosystems Completes $28.5 Million Series B Financing
Devices Dermatology Venture Capital Personnel
 HSMN NewsFeed - 7 May 2018
Amneal Initiates Phase 3 Study for IPX203, an Investigational Extended-Release Formulation of Carbidopa-Levodopa (CD-LD) in Advanced Parkinson's Disease Patients
Biopharmaceutical Neurology
 HSMN NewsFeed - 17 Apr 2018
King-Devick technologies receives FDA clearance for K-D Balance(TM) App
Devices FDA
 HSMN NewsFeed - 26 Mar 2018
Bioness Receives FDA Clearance for myBioness(TM) iOS app for mobile control of the L300 Go(TM) System
Devices FDA
 HSMN NewsFeed - 4 Jan 2018
Acacia Pharma Announces FDA Acceptance of NDA Filing For BAREMSIS(R) for the Management of Post-operative Nausea & Vomiting
Biopharmaceuticals FDA
 HSMN NewsFeed - 13 Nov 2017
Allergan Receives FDA Approval For Use of VRAYLAR(TM) (cariprazine) in the Maintenance Treatment of Schizophrenia
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 2 Oct 2017
Biohaven Reports Negative Topline Data from Spinocerebellar Ataxia (SCA) Phase 2/3 Trial
Biopharmaceuticals Neurology
 HSMN NewsFeed - 21 Apr 2017
Neurocrine Announces INGREZZA(TM) Long-Term Safety and Efficacy Data to be Presented at the 2017 American Academy of Neurology Annual Meeting
Biopharmaceuticals Neurology
 HSMN NewsFeed - 11 Apr 2017
Valeo Pharma and Zambon form partnership for Parkinson's Disease Treatment Xadago(R) (safinamide) in Canada
Biopharmaceuticals Neurology Licensing
 HSMN NewsFeed - 4 Apr 2017
Synchron Inc. Secures $10 Million in Series A Financing Round
Devices Neurology Venture Capital
 HSMN NewsFeed - 4 Apr 2017
Teva Announces FDA Approval of AUSTEDO(TM) (deutetrabenazine) Tablets for the Treatment of Chorea Associated with Huntington’s Disease
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 10 Feb 2017
FDA Approves EMFLAZA(TM) (deflazacort) Tablets and Oral Suspension for the Treatment of Duchenne Muscular Dystrophy in Patients 5 Years and Older
Biopharmaceuticals FDA
 HSMN NewsFeed - 7 Feb 2017
Bioness Receives FDA Clearance for the L300 Go(TM) System
Devices Orthopaedic FDA
 HSMN NewsFeed - 30 Nov 2016
Neurocrine Announces FDA Advisory Committee Meeting to Review INGREZZA(TM) (valbenazine) New Drug Application for the Treatment of Tardive Dyskinesia
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 11 Oct 2016
Neurocrine Announces INGREZZA(TM) (valbenazine) New Drug Application for the Treatment of Tardive Dyskinesia has been Accepted for Priority Review by U.S. FDA
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 4 Oct 2016
EUSA Pharma Acquires Global Rights to Neuroblastoma Treatment Isqette(R) (Dinutuximab Beta) from Apeiron Biologics
Biopharmaceuticals Oncology Acqusitions
 HSMN NewsFeed - 23 May 2016
Zambon Launches Xadago(R) (Safinamide) in the U.K. for Patients with Mid- to Late-Stage Parkinson’s Disease
Biopharmaceuticals Neurology Product Launch
 HSMN NewsFeed - 15 Mar 2016
Nuviant Medical Names Brian Blischak Chief Commercial Officer
Devices Neurology Personnel
 HSMN NewsFeed - 2 Feb 2016
Neurocrine Announces Initiation of Phase II Clinical Study of VMAT2 Inhibitor Valbenazine in Children and Adolescents with Tourette Syndrome
Biopharmaceuticals Neurology
 HSMN NewsFeed - 22 Oct 2015
INSIGHTEC Submits Pre-Market Application (PMA) for FDA Approval of Exablate Neuro for Treatment of Essential Tremor
Devices Neurology Neurosurgery FDA
 HSMN NewsFeed - 15 Sep 2015
Marathon Pharmaceuticals Names Dr. Jordan Dubow Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Jul 2015
Revance Therapeutics Announces Change in Role of Jacob Waugh, M.D.
Biopharmaceuticals Drug Delivery Dermatology Personnel
 HSMN NewsFeed - 23 Mar 2015
EUSA Pharma Successfully Launches as an Independent Profitable Pharmaceutical Business with Global Reach and a Portfolio of Specialty Products Acquired from Jazz Pharmaceuticals
Biopharmaceuticals Acquisitions Product Launch
 HSMN NewsFeed - 17 Sep 2014
Boston Scientific Receives CE Mark For The Vercise(TM) Deep Brain Stimulation (DBS) System For Treating Patients With Tremor
Devices Neurosurgery Regulatory
 HSMN NewsFeed - 11 Jul 2014
Ipsen and Galderma become exclusive partners for development and marketing of neurotoxins in the US, Canada, Brazil and Europe1
Biopharmaceuticals Dermatology Distribution
 HSMN NewsFeed - 28 Apr 2014
Cyberonics Names Rohan Hoare, Ph.D. Chief Operating Officer And O'Neill D'Cruz, M.D. Chief Medical Officer
Devices Personnel
 HSMN NewsFeed - 5 Dec 2013
First U.S. Implants of New Medtronic Deep Brain Stimulation System Advance Ground-Breaking Research Into Brain Activity While Therapy Is Delivered
Devices Neurology Personalized Medicine
 HSMN NewsFeed - 3 Dec 2013
Toshiba’s Innovative MR Applications Improve Diagnostic Accuracy and Patient Safety
Devices Radiology
 HSMN NewsFeed - 21 Nov 2013
Forest Laboratories and Gedeon Richter Receive Complete Response Letter for Cariprazine
Biopharmaceuticals FDA
 HSMN NewsFeed - 19 Nov 2013
Boston Scientific Vercise(TM) Deep Brain Stimulation System Receives CE Mark Approval for Treatment of Dystonia
Devices Neurosurgery Regulatory
 HSMN NewsFeed - 17 Oct 2013
Auspex Appoints Pratik Shah as CEO and Expands Executive Team
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 30 Sep 2013
FDA Grants Orphan Drug Designation to Omeros' OMS824 for Huntington's Disease
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 12 Sep 2013
Cyberonics Names Rohan J. Hoare, Ph.D. Senior Vice President, Strategic Planning
Devices Neurology Personnel
 HSMN NewsFeed - 15 Aug 2013
Intronix Technologies Attending AAPM&R Event to Share Myoguide(TM), Latest Guided Injection System Breakthrough
Devices Drug Delivery Distribution
 HSMN NewsFeed - 7 Aug 2013
New Medtronic Deep Brain Stimulation System the First to Sense and Record Brain Activity While Delivering Therapy
Devices Neurology
 HSMN NewsFeed - 6 Aug 2013
Medtronic Introduces the First and Only Neurostimulation Systems for Chronic Pain Designed for Full-Body MRI Safety*
Devices Neurology Product Launch
 HSMN NewsFeed - 5 Aug 2013
Merz North America Announces the Appointment of John Donofrio as Chief Financial Officer and Head of North American Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Jun 2013
Boston Scientific Vercise(TM) DBS System demonstrates Improvement In Motor Function For Patients With Parkinson's Disease
Devices Neurosurgery
 HSMN NewsFeed - 23 Apr 2013
FDA Approves Second Drug in BD Simplist(TM) Prefilled Injectable Line of Products
Biopharmaceuticals Devices Drug Delivery Generics FDA
 HSMN NewsFeed - 5 Mar 2013
Catalyst Pharmaceutical Partners Appoints Dr. Bernardino Mosquera as Vice President of Clinical Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Nov 2012
Auspex Pharmaceuticals Closes $25 Million Series D Financing
Biopharmaceuticals Neurology Venture Capital Personnel
 HSMN NewsFeed - 17 Sep 2012
Merz, Inc. Announces Cynthia Schwalm as Vice President, Neurology
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 16 Jul 2012
UCB Launches Neupro(R) in the U.S. to Treat Parkinson’s Disease and Restless Legs Syndrome
Biopharmaceuticals Neurology Drug Delivery
 HSMN NewsFeed - 29 May 2012
Eisai Gains Positive CHMP Opinion for Fycompa(R) (perampanel) First in a New Class of Treatment for Partial Onset Epilepsy
Biopharmaceuticals Neurology Regulatory
 HSMN NewsFeed - 3 Apr 2012
Neupro(R) Approved by U.S. FDA for Parkinson’s Disease and Restless Legs Syndrome
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 15 Mar 2012
Medtronic Receives Health Canada License for Deep Brain Stimulation Therapy in Refractory Epilepsy Patients
Devices Neurology Regulatory
 HSMN NewsFeed - 11 Jan 2012
Results of St. Jude Medical’s First Controlled Study of Deep Brain Stimulation Confirms Benefit of Constant Current System for Patients with Parkinson’s Disease
Devices Neurology
 HSMN NewsFeed - 3 Jan 2012
Enrollment in First MRgFUS Essential Tremor Feasibility Trial Completed
Devices Neurosurgery
 HSMN NewsFeed - 21 Dec 2011
Impax Pharmaceuticals Submits New Drug Application for IPX066 in Parkinson’s Disease
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 16 Mar 2011
Medtronic Announces Launch of Activa(R) SC Deep Brain Stimulation System
Devices Neurology
 HSMN NewsFeed - 23 Feb 2011
Allon Appoints Dr. Michael Gold Chief Medical Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 16 Dec 2010
GlaxoSmithKline and Impax Pharmaceuticals Enter Global Agreement to Develop and Commercialize a late stage compound for Parkinson’s Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 23 Nov 2010
FDA Approves Movement Disorder Drug from CNS Therapeutics: Gablofen(R) (Baclofen Injection) for the Treatment of Severe Spasticity
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 18 Oct 2010
Integra LifeSciences Introduces the CRW Precision(TM) Arc Stereotactic System for Use in Stereotactic Frame-Based Neurosurgery
Devices Neurosurgery
 HSMN NewsFeed - 2 Aug 2010
FDA Approves Merz Pharmaceuticals' Xeomin(R) (incobotulinumtoxinA) for the Treatment of Cervical Dystonia and Blepharospasm
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 29 Jul 2010
Medtronic Launches Novel Clinical Trial Evaluating Spinal Cord Stimulation Therapy for Heart Failure
Devices Cardiology Neurosurgery
 HSMN NewsFeed - 28 Jul 2010
Study Showed the Clinically Significant Therapeutic Benefit of Neupro(R) (rotigotine transdermal system) in the Treatment of Restless Legs Syndrome
Biopharmaceuticals
 HSMN NewsFeed - 18 Jun 2010
Neupro(R) (rotigotine) significantly improved wellbeing and daily activities impaired due to limb pain associated with Restless Legs Syndrome
Biopharmaceuticals
 HSMN NewsFeed - 17 Jun 2010
Neupro(R) (rotigotine transdermal system) Showed Significant Benefit on Early Morning Motor Control, Sleep and Nocturnal Symptoms in Patients With Parkinson's Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 6 May 2010
Medtronic Announces Clinical Trial for Breakthrough Technology in Neurostimulation Therapy for Intractable Chronic Pain
Devices Neurology
 HSMN NewsFeed - 6 May 2010
Dicerna Names Douglas Fambrough as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Apr 2010
Aton Pharma Acquires Parkinson's Drug LODOSYN(R) (carbidopa)
Biopharmaceuticals Neurology Acquisitions
 HSMN NewsFeed - 15 Apr 2010
Impax Pharmaceuticals Completes Enrollment in APEX-PD Phase III Trial of IPX066 in Parkinson's Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 13 Apr 2010
New Data Show Sustained 5-Year Benefit of Neupro(R) (Rotigotine Transdermal System) for Symptoms of Restless Legs Syndrome
Biopharmaceuticals Neurology Drug Delivery
 HSMN NewsFeed - 23 Mar 2010
St. Jude Medical Receives Australian TGA Regulatory and Reimbursement Approval for World's Smallest Rechargeable Deep Brain Stimulator for Parkinson's Disease
Devices Regulatory Neurology
 HSMN NewsFeed - 12 Mar 2010
Manhattan Pharmaceuticals Completes Merger Transaction With Ariston Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 22 Feb 2010
FDA Approves Once-Daily MIRAPEX ER for the Treatment of Early Parkinson's Disease
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 16 Feb 2010
Medtronic: Advanced Deep Brain Stimulation Therapy Now Available in Canada
Devices Neurology Neurosurgery Regulatory
 HSMN NewsFeed - 2 Nov 2009
Pico-Tesla Starts Pilot Study for Type 2 Diabetes with its Proprietary Magnetic (Magneceutical) Therapy
Devices Endocrinology
 HSMN NewsFeed - 5 Oct 2009
Pico-Tesla Starts Phase III Clinical Trial of Its Proprietary Magnetic (Magneceutical) Therapy for Parkinson's Disease
Devices Neurology
 HSMN NewsFeed - 8 Sep 2009
Salix Receives FDA Marketing Approval for METOZOLV ODT (Orally Disintegrating Tablets) for Relief of Diabetic Gastroparesis and Symptomatic Documented GERD
Biopharmaceuticals Gastroenterology FDA
 HSMN NewsFeed - 24 Aug 2009
Biovail to Acquire Rights to Develop, Commercialize JP-1730/Fipamezole in North America from Santhera
Biopharmaceuticals Neurology
 HSMN NewsFeed - 5 Aug 2009
Ceregene Receives Additional Grant From Michael J. Fox Foundation to Expand Long-Term Testing of CERE-120 Patients
Biopharmaceuticals Neurology
 HSMN NewsFeed - 14 Jul 2009
A Swiss Team Uses Transcranial MR-Guided Focused Ultrasound to Treat Patients With Functional Brain Disorders
Devices Neurosurgery
 HSMN NewsFeed - 12 Jun 2009
Clinical Data Presented at International Congress Showed Treatment With Neupro(R) (rotigotine) Significantly Improved Early Morning akinesia and was Generally Well Tolerated Over Four Years
Biopharmaceuticals Neurology
 HSMN NewsFeed - 8 Jun 2009
St. Jude Medical Completes Implants in U.S. Study of Deep Brain Stimulation for Parkinson's Disease
Devices Neurology
 HSMN NewsFeed - 21 May 2009
Medtronic Announces FDA Approval of Two Deep Brain Stimulation Devices That Offer Programming Advances and New Tools for Patients with Movement Disorders
Devices Neurology FDA
 HSMN NewsFeed - 18 May 2009
FDA Grants Approval for Use of RISPERDAL(R) CONSTA(R) as Both a Monotherapy and Adjunctive Therapy in the Maintenance Treatment of Bipolar I Disorder
Biopharmaceuticals FDA
 HSMN NewsFeed - 18 May 2009
Biovail Announces Acquisition of Worldwide Rights to Tetrabenazine
Biopharmaceuticals Neurology Acquisitions
 HSMN NewsFeed - 14 May 2009
Study Shows Piclozotan Improves Both Dyskinesia and OFF Time in Parkinson's Disease Patients On Levodopa Therapy
Biopharmaceuticals Neurology
 HSMN NewsFeed - 7 May 2009
Merck Serono Initiates SETTLE, the Second Phase III Clinical Trial of Safinamide in Advanced Parkinson's Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 30 Apr 2009
FDA Approves Dysport(TM) for Therapeutic and Aesthetic Uses
Biopharmaceuticals FDA
 HSMN NewsFeed - 19 Feb 2009
Medtronic Receives FDA HDE Approval to Commercialize the First Deep Brain Stimulation (DBS) Therapy for a Psychiatric Indication in the United States
Devices Neurology
 HSMN NewsFeed - 12 Feb 2009
Otsuka America Pharmaceutical, Inc. Announces the Appointment of Mark Altmeyer as President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Feb 2009
FDA Issues Complete Response Letter for RISPERDAL(R) CONSTA(R) for the Adjunctive Maintenance Treatment of Bipolar Disorder
Biopharmaceuticals FDA
 HSMN NewsFeed - 6 Feb 2009
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Announces FDA Filings for Paliperidone Palmitate and INVEGA(R)
Biopharmaceuticals FDA
 HSMN NewsFeed - 3 Feb 2009
Merck Serono's Safinamide Significantly Improved Motor Function in Patients With Advanced Parkinson's Disease in a Phase III Pivotal Trial
Biopharmaceuticals Neurology
 HSMN NewsFeed - 8 Dec 2008
Cambridge Laboratories Announces Approval of Tetrabenazine in Spain
Biopharmaceuticals Reimbursement Distribution
 HSMN NewsFeed - 3 Sep 2008
Neurologix Licenses Exclusive Rights to Key Gene from Aegera Therapeutics for Use as a Potential Gene Therapy for Huntington's Disease
Biopharmaceuticals Neurology Licensing
 HSMN NewsFeed - 18 Aug 2008
Cambridge Laboratories Announces FDA Approval of XENAZINE(R) (tetrabenazine) in the US
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 15 Aug 2008
XENAZINE(R) (Tetrabenazine) Approved by FDA for Patients with Chorea Associated with Huntington's Disease
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 13 Jun 2008
U.S. FDA Approves Requip(R) XL(TM), the First and Only Oral Once-Daily Non-Ergot Dopamine Agonist for Parkinson's Disease
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 7 May 2008
Treatment with Paliperidone ER May Be Associated with Significantly Reduced Use of Mental Health Resources
Biopharmaceuticals
 HSMN NewsFeed - 28 Apr 2008
Clinical Data on the Use of Medtronic's Deep Brain Stimulation System for Psychiatric Disorders to Be Presented at International Neurosurgical Meeting
Devices Neurosurgery
 HSMN NewsFeed - 17 Apr 2008
Alseres Pharmaceuticals Expands Sites for the First Stage of the ALTROPANE(R) Phase III Clinical Trial Program
Biopharmaceuticals Diagnostics Neurology
 HSMN NewsFeed - 16 Apr 2008
Medtronic Activa(R) Deep Brain Stimulation Patient Referral Advisor Software Launched in United States
Devices Neurology
 HSMN NewsFeed - 11 Apr 2008
Status of the E2007 (perampanel) Development Program - Termination of Parkinson's Disease Clinical Development and Focus on Neuropathic Pain and Epilepsy Indications
Biopharmaceuticals
 HSMN NewsFeed - 6 Feb 2008
Medtronic Receives U.S. FDA Approval for New Neurostimulator with Innovative Patient Programmer
Devices Neurology Pain Management FDA
 HSMN NewsFeed - 31 Jan 2008
Ipsen: FDA Accepts for Filing a Biologics License Application (BLA) for Dysport(R) in Cervical Dystonia
Biopharmaceuticals
 HSMN NewsFeed - 29 Jan 2008
Pipex Pharmaceuticals Provides Update on COPREXA (Oral Tetrathiomolybdate) New Drug Application
Biopharmaceuticals Neurology
 HSMN NewsFeed - 14 Jan 2008
Cannasat Therapeutics Appoints Dr. Julia Levy to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Dec 2007
Neupro(R) Filed with the FDA for the Treatment of Advanced-Stage Parkinson's Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 12 Dec 2007
INVEGA(TM) Shows Favorable Long-Term Safety Profile in a One-Year Study of Patients With Schizophrenia
Biopharmaceuticals
 HSMN NewsFeed - 6 Dec 2007
Ipsen Grants Galderma Exclusive Rights to Promote and Distribute Dysport(R) in Aesthetic Medicine and Dermatological Indications in Brazil, Argentina and Paraguay
Biopharmaceuticals Distribution Dermatology
 HSMN NewsFeed - 3 Dec 2007
Researchers Report Results from Study of Brain Electrical Activity Using Cyberkinetics' NeuroPort(TM) System at the American Epilepsy Society Meeting
Devices Neurology
 HSMN NewsFeed - 1 Nov 2007
Medtronic Initiates Long-Term, Post-Market Study with InterStim(R) Therapy for Overactive Bladder
Devices Urology Neurology
 HSMN NewsFeed - 29 Oct 2007
Johnson & Johnson Pharmaceutical Research & Development Submits New Drug Application for Paliperidone Palmitate
Biopharmaceuticals FDA
 HSMN NewsFeed - 16 Oct 2007
CeNeRx BioPharma Adds Dr. Daniel Burch as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Oct 2007
Neupro(R) (Rotigotine Transdermal System) Effective in Controlling Early Morning Motor Impairment and Generally Well-Tolerated for Long-Term Use in Patients with Parkinson's Disease
Biopharmaceuticals Neurology Drug Delivery
 HSMN NewsFeed - 26 Sep 2007
EnVivo Pharmaceuticals Announces Executive Appointment
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Sep 2007
Pipex Pharmaceuticals Plans November NDA Filing for COPREXA Based on Pre-NDA Meetings With FDA
Biopharmaceuticals Neurology
 HSMN NewsFeed - 14 Sep 2007
Study Shows Medtronic Neurostimulation Therapy Improves Chronic Neuropathic Leg and Back Pain
Devices
 HSMN NewsFeed - 22 Aug 2007
FDA Approves RISPERDAL(R) to Treat Adolescents with Schizophrenia and Children and Adolescents with Bipolar Mania
Biopharmaceuticals FDA
 HSMN NewsFeed - 28 Jun 2007
INVEGA(TM) Receives Marketing Authorization In European Union For Treatment Of Schizophrenia
Biopharmaceuticals Drug Delivery Regulatory
 HSMN NewsFeed - 21 Jun 2007
Ceregene and Genzyme Announce Partnership for the Development and Commercialization of Cere-120 for Parkinson's Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 21 Jun 2007
FDA Issues Approvable Letter for RISPERDAL(R) to Treat Adolescents with Schizophrenia and Children and Adolescents with Bipolar Mania
Biopharmaceuticals FDA
 HSMN NewsFeed - 18 Jun 2007
Medtronic Receives FDA Approval for New Tripolar, 16-Electrode Neurostimulation Lead to Treat Chronic Pain
Devices FDA
 HSMN NewsFeed - 18 Jun 2007
Gene Logic Collaboration Reveals Genomic Predictors of Parkinson's Disease
Diagnostics Biopharmaceuticals Neurology
 HSMN NewsFeed - 8 Jun 2007
International Movement Disorder Specialists Receive New Information About the Use of Once-Daily AZILECT(R) in the Treatment of Parkinson's Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 17 May 2007
CVRx(R), Inc. Appoints Todd Langevin Senior Vice President of Clinical and Commercial Development
Devices Personnel
 HSMN NewsFeed - 15 May 2007
Solstice Neurosciences, Inc. Announces Commercialization Agreement
Biopharmaceuticals
 HSMN NewsFeed - 9 May 2007
Somaxon Pharmaceuticals Provides Update on SILENOR(TM) Development Program
Biopharmaceuticals
 HSMN NewsFeed - 1 May 2007
CleveMed Receives FDA Clearance to Market Wireless Movement Disorder Monitor
Devices Neurology Monitoring
 HSMN NewsFeed - 27 Apr 2007
FDA Approves INVEGA (TM) for Long-Term Maintenance Treatment of Schizophrenia
Biopharmaceuticals FDA
 HSMN NewsFeed - 24 Apr 2007
Amarin Reports Top-Line Results of two Phase III Studies of Miraxion in Huntington's Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 17 Apr 2007
Integra LifeSciences Releases New Brain Mapping Software to Treat Parkinson's Disease
Devices Neurology
 HSMN NewsFeed - 13 Apr 2007
Ceregene Enrolling Patients for Phase 2 Clinical Trial of Parkinson's Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 12 Apr 2007
Medtronic Wins Medical Design Excellence Awards for Products Related to Activa(R) Deep Brain Stimulation Therapy and Ear, Nose and Throat Surgery
Devices
 HSMN NewsFeed - 11 Apr 2007
Kansas University Medical Center's Movement Disorder Program Acquires the Most Trusted Stereotactic Image-Guided Platform
Devices Neurosurgery
 HSMN NewsFeed - 5 Apr 2007
One of the Largest-Ever Parkinson's Disease Studies Initiated Across the United States
Biopharmaceuticals Neurology
 HSMN NewsFeed - 3 Apr 2007
Somaxon Pharmaceuticals Names James L'Italien, Ph.D. Senior Vice President, Regulatory Affairs and Quality Assurance
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Apr 2007
Once Daily, Extended-Release Ropinirole Improves Parkinson's Symptoms in Patients not Optimally Controlled With Levodopa
Biopharmaceuticals Neurology
 HSMN NewsFeed - 30 Mar 2007
Study Suggests INVEGA(TM) Helps Patients With Schizophrenia Maintain Symptom Control
Biopharmaceuticals
 HSMN NewsFeed - 1 Mar 2007
FDA Grants Pediatric Exclusivity for RISPERDAL(R)
Biopharmaceuticals FDA
 HSMN NewsFeed - 9 Feb 2007
Integra LifeSciences Adds PET Imaging to Its Cancer Fighting XKnife System
Devices Radiology
 HSMN NewsFeed - 29 Jan 2007
Somaxon Pharmaceuticals Names Robert Jones Vice President, Human Resources
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Dec 2006
INVEGA(TM) Approved By FDA as New Treatment for Schizophrenia
Biopharmaceuticals FDA
 HSMN NewsFeed - 18 Dec 2006
Somaxon's SILENOR(TM) Demonstrates Positive Results in Long-Term Phase 3 Clinical Trial in Elderly Patients with Insomnia
Biopharmaceuticals
 HSMN NewsFeed - 4 Dec 2006
NBI Development Closes $5.5 Million in Seed Round Financing
Devices Neurology Venture Capital
 HSMN NewsFeed - 20 Nov 2006
Somaxon Pharmaceuticals' SILENOR(TM) Demonstrates Positive Results in Its Third Phase 3 Clinical Trial in Insomnia
Biopharmaceuticals
 HSMN NewsFeed - 19 Nov 2006
Somaxon Pharmaceuticals to Announce Results of Phase 3 Clinical Trial of SILENOR(TM) for the Treatment of Insomnia in Elderly Patients and Host Conference Call
Biopharmaceuticals
 HSMN NewsFeed - 13 Nov 2006
Somaxon Pharmaceuticals Names Brian Dorsey Vice President of Manufacturing and Program Management
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Nov 2006
Deep Brain Stimulation Benefits Primary Dystonia Sufferers Says Study Published in New England Journal of Medicine
Devices Neurology
 HSMN NewsFeed - 8 Nov 2006
Solstice Neurosciences Raises $85 Million in Private Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 31 Oct 2006
Boehringer Ingelheim Launches PROUD Study to Explore Possible Disease-Modifying Effect of Pramipexole
Biopharmaceuticals Neurology
 HSMN NewsFeed - 23 Oct 2006
Somaxon Pharmaceuticals' SILENOR(TM) Demonstrates Positive Results in a Phase 3 Transient Insomnia Clinical Trial
Biopharmaceuticals
 HSMN NewsFeed - 6 Oct 2006
FDA Approves RISPERDAL(R) for Treatment of Irritability Associated with Autistic Disorder
Biopharmaceuticals FDA
 HSMN NewsFeed - 25 Sep 2006
Boston Life Sciences, Inc. Announces Findings from Review of POET-1 Study of ALTROPANE(R) Molecular Imaging Agent
Biopharmaceuticals Radiology Neurology
 HSMN NewsFeed - 19 Jul 2006
Somaxon Pharmaceuticals Provides Update on SILENOR(TM) Development Program for the Treatment of Insomnia
Biopharmaceuticals
 HSMN NewsFeed - 17 May 2006
Amarin Acquires Parkinson's Disease Drug Candidate
Biopharmaceuticals Neurology Acquisitions
 HSMN NewsFeed - 15 May 2006
Somaxon Pharmaceuticals Names Matthew Onaitis Vice President of Legal Affairs
Biopharmaceuticals Personnel
Return to NewsFeed  

 Additional items found! 77

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 77 additional stories matching:
movement disorder
(Password required)
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!